Robaxisal and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Robaxisal (aspirin; methocarbamol) and Profen (ibuprofen). Common drug interactions include dyspnoea among females and suicide attempt among males.

The phase IV clinical study analyzes what interactions people have when they take Robaxisal and Profen. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Robaxisal?

Robaxisal has active ingredients of aspirin; methocarbamol. It is often used in back pain. eHealthMe is studying from 223 Robaxisal users. Check the latest studies of Robaxisal.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.



On Jul, 27, 2026

61 people who take Robaxisal and Profen together, and have interactions are studied.

Robaxisal and Profen drug interactions.

What are the common drug interactions of Robaxisal and Profen, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Asthenia (weakness)
  3. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Asthma
  7. Blood pressure increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Constipation
  10. Dizziness

male:

  1. Suicide attempt
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Proteinuria (presence of protein in the urine)
  4. Cytomegalovirus enteritis (virus infection of intestine)
  5. Diarrhoea
  6. Electrolyte imbalance
  7. Mycobacterium avium complex infection
  8. Suicidal ideation
  9. Abdominal pain
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

What are the common drug interactions of Robaxisal and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Suicide attempt
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Renal failure (kidney dysfunction)
  4. Poisoning deliberate
  5. Lactic acidosis (low ph in body tissues)
  6. Dizziness
  7. Nausea (feeling of having an urge to vomit)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Tachypnoea (a condition of rapid breathing over 20 per minute)
  10. Oliguria (not enough urine)

20-29:

n/a

30-39:

  1. Hepatic failure (liver failure)

40-49:

  1. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypovolaemia (a decreased volume of circulating blood in the body)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Asthma
  4. Blood pressure increased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Constipation
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

  1. Asthenia (weakness)
  2. Abdominal pain
  3. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  4. Duodenal ulcer
  5. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Haemoglobin decreased
  8. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  9. Melaena (the passage of black, tarry stools)
  10. Therapeutic response decreased (less preventive response)

What are the existing conditions these people have? *

  1. Suicide Attempt: 9 people, 14.75%
  2. Asthma: 6 people, 9.84%
  3. Stress And Anxiety: 4 people, 6.56%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxisal and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Robaxisal and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Robaxisal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robaxisal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aspirin; methocarbamol and ibuprofen (the active ingredients of Robaxisal and Profen, respectively), and Robaxisal and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: